Dedicated to Finding New Medicines by Targeting the Ubiquitin Proteasome System and PROTAC®s

Our Focus

Progenra’s mission is to leverage its expertise in the ubiquitin proteasome system and cellular protein regulation, acquired over several years, to discover and develop novel, first in class medicines to fill unmet needs in a spectrum of therapeutic areas.

Learn More…

News

Progenra and the Frederick National Laboratory for Cancer Research Establish a contractor Cooperative Research and Development Agreement (cCRADA) to Develop KRAS Degraders for Cancer Therapy

Blog

The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease

The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease Progenra Inc, February 2023 Parkinson’s disease (PD) is the most common neurodegenerative movement disorder. There are no available therapeutics that slow or halt the progressive loss of...

Leadership in Ubiquitin Drug Discovery

UbiPro Platform

PROTAC Platform

Therapeutic Areas